Lipid soluble smoke particles upregulate endothelin receptors in rat basilar artery

Toxicology Letters

Volumn 197, Issue 3, 2010, Pages 243-255

  Huang, Lin Hong ^a   He, Jian Yu ^a   Yuan, Bing Xiang ^a   Cao, Yong Xiao ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Basilar artery; Endothelin receptor; Rat; Smoking

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CIGARETTE SMOKE; CYCLOHEXIMIDE; DACTINOMYCIN; DIMETHYL SULFOXIDE; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR AGONIST; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; SARAFOTOXIN S6C; STAUROSPORINE; STRESS ACTIVATED PROTEIN KINASE; WEDELOLACTONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; BASILAR ARTERY; IMMUNOHISTOCHEMISTRY; MUSCLE CONTRACTION; MYOGRAPHY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; UPREGULATION;

RATTUS;

EID: 77954958585     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2010.06.006     Document Type: Article

References (38)

1. Alessi D.R., Cuenda A., Cohen P., Dudley D.T., Saltiel A.R. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 1995, 270:27489-27494.
2. Alm R., Edvinsson L., Malmsjo M. Organ culture: a new model for vascular endothelium dysfunction. BMC Cardiovasc. Disord. 2002, 2:8.
3. Baykaner M.K. Evidence for the participation of vascular endothelium originated humoral factors to cerebral vasospasm. Acta Neurochir. (Wien) 1993, 124:135-138.
4. Bennett B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., Leisten J.C., Motiwala A., Pierce S., Satoh Y., Bhagwat S.S., Manning A.M., Anderson D.W. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:13681-13686.
5. Bergdahl A., Valdemarsson S., Adner M., Sun X.Y., Hedner T., Edvinsson L. Enhanced endothelin-1-induced contractions in mesenteric arteries from rats with congestive heart failure: role of ET(B) receptors. Eur. J. Heart Fail. 2001, 3:293-299.
6. Bonita R., Duncan J., Truelsen T., Jackson R.T., Beaglehole R. Passive smoking as well as active smoking increases the risk of acute stroke. Tob. Control 1999, 8:156-160.
7. Conklin D.J., Haberzettl P., Prough R.A., Bhatnagar A. Glutathione-S-transferase P protects against endothelial dysfunction induced by exposure to tobacco smoke. Am. J. Physiol. Heart Circ. Physiol. 2009, 296:1586-1597.
8. Cuenda A., Rouse J., Doza Y.N., Meier R., Cohen P., Gallagher T.F., Young P.R., Lee J.C. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 1995, 364:229-233.
9. Dagassan P.H., Breu V., Clozel M., Kunzli A., Vogt P., Turina M., Kiowski W., Clozel J.P. Up-regulation of endothelin-B receptors in atherosclerotic human coronary arteries. J. Cardiovasc. Pharmacol. 1996, 27:147-153.
10. Dawson D.A., Sugano H., McCarron R.M., Hallenbeck J.M., Spatz M. Endothelin receptor antagonist preserves microvascular perfusion and reduces ischemic brain damage following permanent focal ischemia. Neurochem. Res. 1999, 24:1499-1505.
11. Ezzati M., Henley S.J., Thun M.J., Lopez A.D. Role of smoking in global and regional cardiovascular mortality. Circulation 2005, 112:489-497.
12. Gourlay S.G., Benowitz N.L. Arteriovenous differences in plasma concentration of nicotine and catecholamines and related cardiovascular effects after smoking, nicotine nasal spray, and intravenous nicotine. Clin. Pharmacol. Ther. 1997, 62:453-463.
13. Granstrom B.W., Xu C.B., Nilsson E., Vikman P., Edvinsson L. Smoking particles enhance endothelin A and endothelin B receptor-mediated contractions by enhancing translation in rat bronchi. BMC Pulm. Med. 2006, 6:6.
14. Hansen-Schwartz J., Hoel N.L., Zhou M., Xu C.B., Svendgaard N.A., Edvinsson L. Subarachnoid hemorrhage enhances endothelin receptor expression and function in rat cerebral arteries. Neurosurgery 2003, 52:1188-1194. 1194-1185.
15. Henningfield J., Stapleton J.M., Benowitz N.L., Grayson R.F., London E.D. Higher levels of nicotine in arterial than in venous blood after cigarette smoking. Drug Alcohol Depend. 1993, 33:23-29.
16. Henriksson M., Xu C.B., Edvinsson L. Importance of ERK1/2 in upregulation of endothelin type B receptors in cerebral arteries. Br. J. Pharmacol. 2004, 142:1155-1161.
17. Holden W.E., Kishiyama S.S., Dong S.P., Osborne M.L. Endothelium-dependent effects of cigarette smoke components on tone of porcine intrapulmonary arteries in vitro. Toxicol. Appl. Pharmacol. 1990, 104:191-199.
18. Iwasa S., Fan J., Shimokama T., Nagata M., Watanabe T. Increased immunoreactivity of endothelin-1 and endothelin B receptor in human atherosclerotic lesions. A possible role in atherogenesis. Atherosclerosis 1999, 146:93-100.
19. Jamali R., Edvinsson L. Involvement of protein kinases on the upregulation of endothelin receptors in rat basilar and mesenteric arteries. Exp. Biol. Med. (Maywood) 2006, 231:403-411.
20. Johnsson E., Maddahi A., Wackenfors A., Edvinsson L. Enhanced expression of contractile endothelin ET(B) receptors in rat coronary artery after organ culture. Eur. J. Pharmacol. 2008, 582:94-101.
21. Kikkawa K., Saito A., Iwasaki H., Ban Y., Yasoshima A., Yamauchi-Kohno R., Hoshino T., Murata S. Prevention of cerebral vasospasm by a novel endothelin receptor antagonist, TA-0201. J. Cardiovasc. Pharmacol. 1999, 34:666-673.
22. Kobori M., Yang Z., Gong D., Heissmeyer V., Zhu H., Jung Y.K., Gakidis M.A., Rao A., Sekine T., Ikegami F., Yuan C., Yuan J. Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibiting the IKK complex. Cell Death Differ. 2004, 11:123-130.
23. Luo G., Jamali R., Cao Y.X., Edvinsson L., Xu C.B. Vascular endothelin ET(B) receptor-mediated contraction requires phosphorylation of ERK1/2 proteins. Eur. J. Pharmacol. 2006, 538:124-131.
24. Malmsjo M., Bergdahl A., Zhao X.H., Sun X.Y., Hedner T., Edvinsson L., Erlinge D. Enhanced acetylcholine and P2Y-receptor stimulated vascular EDHF-dilatation in congestive heart failure. Cardiovasc. Res. 1999, 43:200-209.
25. B receptor mRNA in human omental arteries after organ culture: quantification by competitive reverse transcription-polymerase chain reaction. Clin. Exp. Pharmacol. Physiol. 1998, 25:788-794.
26. Nilsson D., Wackenfors A., Gustafsson L., Ugander M., Ingemansson R., Edvinsson L., Malmsjo M. PKC and MAPK signalling pathways regulate vascular endothelin receptor expression. Eur. J. Pharmacol. 2008, 580:190-200.
27. Ono K., Han J. The p38 signal transduction pathway: activation and function. Cell Signal. 2000, 12:1-13.
28. Pernow J., Bohm F., Johansson B.L., Hedin U., Ryden L. Enhanced vasoconstrictor response to endothelin-B-receptor stimulation in patients with atherosclerosis. J. Cardiovasc. Pharmacol. 2000, 36:S418-420.
29. Pessah-Rasmussen H., Stavenow L., Xu C.B., Berglund A. Increased smooth muscle cell proliferation by dimethylbenzanthracene is correlated to variations in activity of ornithine decarboxylase but not arylhydrocarbonhydroxylase. Artery 1991, 18:240-255.
30. Quillen J.E., Rossen J.D., Oskarsson H.J., Minor R.L., Lopez A.G., Winniford M.D. Acute effect of cigarette smoking on the coronary circulation: Constriction of epicardial and resistance vessels. J. Am. Coll. Cardiol. 1993, 22:642-647.
31. Uddman E., Henriksson M., Eskesen K., Edvinsson L. Role of mitogen-activated protein kinases in endothelin ETB receptor up-regulation after organ culture of rat mesenteric artery. Eur. J. Pharmacol. 2003, 482:39-47.
32. Wackenfors A., Emilson M., Ingemansson R., Hortobagyi T., Szok D., Tajti J., Vecsei L., Edvinsson L., Malmsjo M. Ischemic heart disease induces upregulation of endothelin receptor mRNA in human coronary arteries. Eur. J. Pharmacol. 2004, 484:103-109.
33. Wainwright C.L., McCabe C., Kane K.A. Endothelin and the ischaemic heart. Curr. Vasc. Pharmacol. 2005, 3:333-341.
34. Xu C.B., Pessah-Rasmussen H., Stavenow L. Interactions between cultured bovine arterial endothelial and smooth muscle cells: effects of injury on the release of growth stimulating and growth inhibiting substances. Pharmacol. Toxicol. 1991, 69:195-200.
35. Xu, C.B., Zheng, J.P., Zhang, W., Zhang, Y.P., Edvinsson, L., 2008. Lipid-soluble smoke particles upregulate vascular smooth muscle ETB Receptors via activation of mitogen-activating protein kinases and NF-kappaB pathways.
36. Zhang J.Y., Cao Y.X., Xu C.B., Edvinsson L. Lipid-soluble smoke particles damage endothelial cells and reduce endothelium-dependent dilatation in rat and man. BMC Cardiovasc. Disord. 2006, 6:3.
37. Zhang J.Y., Cao L., Zheng X.H., Xu C.B., Cao Y.X. Dimethylsulfoxide-soluble smoking particles and nicotine affect vascular contractibility. Arch. Pharm. Res. 2009, 32:1475-1481.
38. Zhu Z.H., Liu J.L., Zhang J.X., He Y.Q. Determination of total nicotine and nicotine by Spectrophotometry. J. Environ. Health 1997, 14:230-232.